Pepinemab in Combination With Pembrolizumab in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
Clinical trial NCT04815720 · COMPLETED
Trial details
- NCT number
- NCT04815720
- Sponsor
- Vaccinex Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-09
- Primary completion
- 2024-07-24
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.